Takeda Pharmaceutical (NYSE:TAK) reported quarterly earnings of $0.47 per share which missed the analyst consensus estimate of $0.55 by 13.64 percent. This is a 7.95 percent increase over earnings of $0.44 per share from the same period last year. The company reported quarterly sales of $7.600 billion which missed the analyst consensus estimate of $8.530 billion by 10.90 percent. This is a 1.16 percent increase over sales of $7.513 billion the same period last year.